Digitoxin is a cardiac glycoside belonging to the cardenolide class, primarily indicated for the treatment of heart failure due to its ability to increase myocardial contractility. Unlike other medications… Read more














Digitoxin is a cardiac glycoside belonging to the cardenolide class, primarily indicated for the treatment of heart failure due to its ability to increase myocardial contractility. Unlike other medications in this class that rely on renal excretion, this compound is primarily eliminated via the liver, often serving as an alternative for patients with compromised kidney function. Pharmaceutical laboratories utilize reference standards of this drug, alongside its associated metabolites and impurities, to perform rigorous analytical testing and quality control. Using high-quality analytical components is essential for reliable impurity profiling and method validation throughout the drug development lifecycle. The inclusion of stable isotope labelled compounds provides critical internal standards for quantitative analysis in complex biological matrices or stability studies. These materials ensure that researchers can accurately identify and quantify trace-level impurities, maintaining compliance with stringent regulatory requirements for potency and purity.